




AN ADIPOSE EXTRACELLULAR MATRIX-DERIVED 










A Dissertation Submitted to Johns Hopkins University in Conformity with the Requirements for 












Title ...................................................................................................................................... i 
Contents .............................................................................................................................. ii 
List of Tables ....................................................................................................................... v 
List of Figures ..................................................................................................................... vi 
Acknowledgments .............................................................................................................. vii 
Abstract .............................................................................................................................. ix 
1. Introduction ................................................................................................................... 1 
2. Adipose Tissue Engineering ............................................................................................ 3 
2.1 Introduction .......................................................................................................... 3 
2.1.1 Current clinical strategies .......................................................................... 4 
2.2 Biomaterials ......................................................................................................... 5 
2.2.1 Synthetic polymers ................................................................................... 5 
2.2.2 Naturally derived scaffolds ........................................................................ 7 
2.2.3 Extracellular matrix- based materials .......................................................... 7 
2.3 Cell sources ........................................................................................................ 11 
2.3.1 Cells of adipose tissue ............................................................................. 11 
2.3.2 Adult stem cells ...................................................................................... 11 
2.3.3 Embryonic stem cells .............................................................................. 12 
2.3.4 Induced pluripotent stem cells .................................................................. 13 
3. Development of an Adipose Matrix – Based Biomaterial ................................................. 14 
3.1 Introduction ........................................................................................................ 14 
3.2 Materials and Methods ........................................................................................ 16 
3.2.1 Adipose extracellular matrix preparation .................................................. 16 
3.2.2 Material characterization ......................................................................... 16 
3.2.3 Crosslinking ........................................................................................... 19 
 ii
 
3.3 Results ............................................................................................................... 20 
3.3.1 Adipose extracellular matrix .................................................................... 20 
3.3.2 Material characterization ......................................................................... 21 
3.3.3 Crosslinking ........................................................................................... 27 
3.4 Discussion .......................................................................................................... 30 
4. In Vitro Bioactivity of the Adipose Extracellular Matrix ................................................. 33 
4.1 Introduction ........................................................................................................ 33 
4.2 Materials and Methods ........................................................................................ 34 
4.2.1 Adipose extracellular matrix preparation .................................................. 34 
4.2.2 Adipose-derived stem cell isolation .......................................................... 35 
4.2.3 In vitro cell studies .................................................................................. 35 
4.3 Results ............................................................................................................... 38 
4.3.1 Cell viability on cross-linked matrices ...................................................... 38 
4.3.2 Migration assay ...................................................................................... 38 
4.3.3 Adipogenic differentiation of cells in 2D culture on the adipose matrices .... 39 
4.3.4 Adipogenic differentiation of cells in 3D constructs comparing the adipose and 
dermis ECM ........................................................................................... 39 
4.3.5 HUVEC tube formation assay .................................................................. 41 
4.4 Discussion .......................................................................................................... 43 
5. The Adipose Extracellular Matrix as a Scaffold for In Vivo Adipose Tissue Regeneration . 46 
5.1 Introduction ........................................................................................................ 46 
5.2 Materials and Methods ........................................................................................ 47 
5.2.1 Adipose extracellular matrix preparation .................................................. 47 
5.2.2 In vivo studies ........................................................................................ 48 
5.2.3 Histology ............................................................................................... 50 
5.2.4 Immunostaining ...................................................................................... 50 
5.3 Results ............................................................................................................... 50 
5.3.1 In vivo biocompatibility of crosslinked adipose ECM ................................ 50 
 iii
 
5.3.2 Long term biocompatibility of adipose ECM ............................................ 51 
5.3.3 In vivo volume retention compared to fat grafting ..................................... 53 
5.3.4 In vivo adipogenesis of  adipose ECM with ASCs ..................................... 54 
5.4 Discussion .......................................................................................................... 57 
6. Discussion and future work ........................................................................................... 60 
BIBLIOGRAPHY ......................................................................................................................... 63 




LIST OF TABLES 
Table 3.1Denaturation peak temperature .......................................................................... 26 




LIST OF FIGURES 
Figure 3.1 Processed adipose tissue matrix ...................................................................... 20 
Figure 3.2 Scanning electron microscopy images of adipose ECM ................................. 21 
Figure 3.3 1D SDS-PAGE gels. ........................................................................................ 23 
Figure 3.4 Proteomic characterization of the adipose and dermis ECM .......................... 24 
Figure 3.5 DSC thermogram of the adipose ECM through the processing stages ........... 26 
Figure 3.6 Mechanical properties of the adipose ECM and commercial fillers ............... 28 
Figure 3.7 Crosslinked matrices show increased resistance to enzymatic degradation. ... 29 
Figure 4.1 LIVE/DEAD staining of cells on crosslinked matrices ................................... 38 
Figure 4.2 In vitro adipogenesis of ASCs seeded on adipose matrix in 2D culture ......... 39 
Figure 4.3 In vitro chemoattractive properties and adipo-inductive capacity .................. 40 
Figure 4.4 HUVEC tube formation assay with adipose ECM. ......................................... 42 
Figure 5.1 In vivo biocompatibility of crosslinked matrices ............................................ 51 
Figure 5.2 In vivo biocompatibility in a rat model ........................................................... 52 
Figure 5.3 De novo adipogenesis at implant periphery .................................................... 52 
Figure 5.4 Comparison of in vivo fat grafting and adipose ECM .................................... 53 





There are many individuals whose help and contributions made this work possible. The members 
of the Elisseeff lab who trained me in the numerous techniques and provided intellectual support 
were critical to the development of this work, as well as my personal development as a 
researcher. Dr. Zayna Nahas pioneered much of the early work that would later become the 
foundation for this thesis. Dr. Alexandra Condé-Green has also been instrumental in the 
development of this work, providing a unique clinical perspective and spent many late nights with 
me working to complete numerous animal studies. Her intellectual curiousity and steady 
optimism always helped keep me focused. Finally, Jeremy Chae has always been willing to lend 
his expertise in veterinary medicine to assist me with my animal studies. 
My advisor Dr. Jennifer Elisseeff, who has always provided guidance for the direction of my 
research and support during times when experiments wouldn’t go as planned, has truly been an 
inspiration with her intellect and unwavering dedication. Under her watchful guidance, I have 
learned invaluable lessons on everything from experimental design to overcoming challenges 
when they are least expected. She has always allowed us to pursue my intellectual interests while 
providing the needed guidance when I stumble upon roadblocks. I greatly appreciate the 
opportunities she has given me and the supportive research environment she has fostered that 
have been crucial to my development and growth. 
I have had the opportunity to work with several fantastic undergraduates who have made this 
work possible. Ian Graham, who has spent countless hours processing tissue with me, has helped 
to make the most laborious of tasks endurable and always tackled it with verve. Carly Loveland 
has helped with nearly every aspect of the project and sped everything up immensely. Tara 
Berglund was the first student I mentored and learned everything quickly to become a wonderful 
research assistant.  
 vii
 
Lastly, I am deeply grateful for all the support from my friends and family who have helped 
me tremendously through this process. My friends, with whom I commiserate after long days at 
lab and uncooperative experiments. My parents Jennifer and Terry Wu, who helped me gain my 
footing in the world and always did everything to give me the best opportunities to succeed. My 
sister Ihui Wu who will always be my partner in crime and has always supported me with her 
wholehearted encouragement. And finally, Ashwan Reddy who has been perfect through this 
entire process, giving me his unwavering support and keeping me grounded when I needed it the 
most. He has survived this sometimes grueling process with his sense of humor intact, keeping 





Soft tissue defects can result from traumatic injury, congenital defects, and medical procedures 
such as tumor resection. Patients who require soft tissue reconstruction have limited options and 
often must use autologous tissue for reconstruction, which has the adverse effects of donor site 
morbidity. This study explores the development of an adipose extracellular matrix – based 
biomaterial for the repair of soft tissue defects. The adipose extracellular matrix (ECM) is 
obtained through mechanical and chemical treatments to remove all the cells and lipids from 
intact human adipose tissue. The degradation properties of the ECM-based biomaterial can be 
modulated with chemical crosslinking, allowing for control over the degradation rate of the 
biomaterial. Material characterization of the adipose ECM was carried out through proteomics, 
mechanical testing, and thermal analysis. The adipose matrix supported adipose stem cell growth 
and differentiation in vitro, providing tissue-specific bioactive cues to improve adipogenic 
differentiation. In vivo biocompatibility studies showed minimal inflammatory response to the 
biomaterial and stable volume retention through 12 week studies. When compared with the 
clinical standard of fat grafting, the acellular adipose matrix demonstrated the advantages of 
facilitating new adipose tissue regeneration rather than relying on transplantation of autologous 
fat which has the risk of necrosis, cyst formation and calcification due to the limited viability of 
transplanted adipocytes. The adipose ECM can also be used with adipose stem cell delivery, 
providing a protective environment for stem cell engraftment, which in turn facilitates new 
adipose tissue formation. The adipose matrix provides a versatile biomaterial for soft tissue 
regeneration hat can be used for allogenic applications, circumventing the need for autologous 
tissue for reconstruction. 
 
Advisor: Jennifer Elisseeff, Ph.D. Reader: Warren Grayson, Ph.D.   
1. Introduction 
Adipose tissue occupies a unique role in providing structural support, establishing contour, and 
serving as a key energy reservoir for the body. As one of the most dynamic tissues of the body, 
the size of the adipose organ can vary considerably both between individuals and within a single 
individual’s lifetime. To accommodate the drastic changes in adipocyte size based on an 
individual’s metabolic state, the extracellular matrix of adipose tissue is highly active and must 
undergo constant remodeling to support the parenchymal cells of adipose tissue. These reasons, 
along with the availability of adipose tissues from common plastic surgery procedures such as 
abdominoplasty and brachioplasty, make the adipose extracellular matrix an intriguing source for 
developing a biomaterial for soft tissue regeneration. 
The field of regenerative medicine develops biomaterials and cell-based approaches to 
regenerate damaged or diseased tissues. Current clinical strategies for soft tissue reconstruction 
highlight the need for regenerative medicine-based therapies. Patients who have significant soft 
tissue loss often require autologous flap reconstructions whereby tissue is removed from a donor 
site to repair the defect, resulting in donor site morbidity. Improved aesthetic outcomes have 
important effects on quality of life and physical and psychological aspects of a patient’s well-
being. Development of an off-the-shelf biomaterial for soft tissue regeneration could provide an 
easily available source for replacing soft tissue in cases of trauma or tumor resection. 
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In the following dissertation, the author investigated the use of an adipose-derived 
biomaterial for application in soft tissue regeneration. The extracellular matrix provides a 
promising scaffold for adipogenesis as it carries out many of the supportive functions for 
adipocytes in vivo, providing not only a biocompatible surface for cell adhesion and growth, but 
also retaining bioactive cues for maintaining adipose tissue function. The extracellular matrix is 
isolated through a series of mechanical and chemical treatments to remove all antigenic 
components including cells and lipids, leaving an acellular biomaterial that can be used 
allogenically without eliciting a severe inflammatory response.  
Due the shortcomings of current reconstructive options, many researchers have tackled the 
challenge of engineering adipose tissues. Chapter 2 of this thesis reviews the current literature 
and state of the art in tissue engineering approaches to adipose tissue regeneration. In Chapter 3, 
we discuss the development of an adipose extracellular matrix-based biomaterial and the design 
considerations framing the process. Additionally, we characterize the biomaterial through 
proteomic, mechanical and thermal analysis. Chapter 4 evaluates the in vitro bioactivity of the 
matrix in supporting cell migration, growth, and differentiation on the scaffold and explores 
tissue specificity of the adipose matrix through comparison with dermal extracellular matrix. In 
Chapter 5, we investigate the in vivo biocompatibility of the biomaterial and its long term 
efficacy in retaining a stable volume. To further evaluate the adipogenic inductive capacity of 
the matrix, we delivered it in conjunction with adipose-derived stem cells to evaluate 
neoadipogenesis in vivo.  
The extracellular matrix of tissues has been found to perform an increasing number of roles 
in supporting tissue function. Through our studies, we demonstrate a way to utilize it as a 
blueprint for tissue regeneration by taking advantage of its innate bioactivity. As a natural 
scaffold for soft tissue reconstruction, the adipose extracellular matrix is an easily accessible 
biomaterial with the potential to facilitate soft tissue repair. 
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2. Adipose Tissue Engineering  
2.1 Introduction 
Soft connective tissues function to provide structural support and establish contour. Soft tissue 
defects present a challenging problem as the aesthetic function is intricately linked with the 
patient’s psychological well-being. As such, the benefits of improved aesthetic outcomes must 
be weighed against the risks from the complicated reconstructive surgeries often required. Soft 
tissue defects can arise from trauma, medical conditions, or after ablative procedures such as 
tumor resection. In addition to the aesthetic function, there are also many negative biological 
sequelae of scar formation involved in soft tissue loss and reconstruction.1 
Traumatic injuries such as those sustained from explosive devices and automotive accidents 
often result in extensive soft tissue loss. Laceration and dog bite repair account for over 320,000 
reconstructive cases performed in 2012, making it the second most common condition requiring 
reconstructive surgery.2 Despite advances in reconstructive procedures, regeneration of damaged 
soft connective tissues has yet to be achieved and autologous flap reconstructions are often the 
only option for replacing areas of soft tissue loss. Significant contour defects and scarring often 
persist, resulting in poor aesthetic outcomes for individuals who have sustained soft tissue 
trauma. 
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In addition to traumatic injury, soft tissue loss can also arise secondary to medical 
conditions or as a result of surgical management of cancer. Lipodystrophy is a condition 
characterized by dysfunction or degenerative loss of adipose tissue and can lead to severe insulin 
resistance and dyslipidaemia.3 There are both acquired and congenital forms and it is often 
associated with antiretroviral therapy for HIV patients. Patients with this condition have a unique 
need for soft tissue replacements as they typically do not have adequate autologous adipose 
tissue available for grafting. Tumor resection is the most common reconstructive surgery carried 
out, with over 4.2 million operations performed annually for tumor removal.2 Without a suitable 
soft tissue replacement, patients typically opt for contralateral reduction, prosthetic implants or 
autologous flap reconstructions to restore symmetry after lumpectomy or mastectomy 
procedures.4 The limited options available highlight the need for an alternative that avoids the 
risk of complications for prosthetic implants and negates the prerequisite of donor site tissue for 
flap reconstruction. 
2.1.1 Current clinical strategies 
For small volume corrections, dermal fillers or fat grafting can be used to fill the defect space 
and restore contour. Dermal fillers range from naturally occurring components of the 
extracellular matrix such as collagen, cross-linked forms of hyaluronic acid, and calcium 
hydroxyapatite, to synthetic polymers including poly-lactic acid and polymethylmethacrylate.5 
However, most dermal fillers are not permanent and require patients to return regularly for 
repeat injections to maintain a proper volume correction and there are a number of known 
complications that can occur with application of specific fillers.6 
Autologous fat grafting is another option and involves harvesting tissue by liposuction at 
one site of the body and reinjecting the lipoaspirate to fill a soft tissue defect. The procedure 
suffers from inconsistent outcomes due to highly variable rates of resorption. To rectify the 
unpredictability of graft take, several groups have established protocols to standardize and 
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improve outcomes through harvest, preparation, and grafting techniques.7,8 However, there are 
still complications that can arise from central necrosis of the transplanted lipoaspirate as poor 
viability results from rupture of adipocytes and lack of oxygen and vascular supply post 
transplantation.9 Cyst formation and calcification often occur secondary to the necrosis and can 
interfere with radiological detection of breast cancer.10  
One of the most common reconstructive procedures to correct loss of soft tissue volume is 
autologous flap reconstruction, where a tissue flap from a donor site in the body is used for the 
reconstruction.  Advances in reconstructive surgery have decreased the associated morbidity by 
attempting to keep the donor site muscle intact when possible.11 However, the basic requirement 
of a donor site to repair a soft tissue defect at another location in the body inevitably results in 
donor site morbidity.12,13 Availability of donor tissue can also be a limiting factor for patients 
who are thin or those who have multiple injury sites. Patients who undergo mastectomy have the 
additional option of prosthetic implants. However, complications can arise including capsular 




2.2.1 Synthetic polymers 
Synthetic polymers commonly used in numerous biomedical devices offer the distinct advantage 
of high level of control over the chemical properties of the polymer. As a scaffold for adipose 
tissue engineering, polylactic acid, polyglycolic acid and copolymers incorporating both have 
been widely investigated due to their ability to degrade over time. These polymers degrade by 
bulk hydrolytic degradation of the ester bonds and the rate of degradation can be modulated by 
changing the molar mass and molar ratios of the monomers. 
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Cells can be combined with synthetic polymers to create a cell-scaffold construct for 
adipose tissue engineering. Several groups have seeded 3T3-L1 preadipocytes15-17 or adipose-
derived stem cells18,19 on polyglycolic acid meshes and observed adipogenesis over time both in 
vitro and in vivo. Electrospun polylactic acid nanofibers were shown to support adipogenic 
differentiation of bone marrow stem cells in vitro. The copolymer of poly(lactic-co-glycolic 
acid) (PLGA) is more commonly used since the degradation rate of the polymer can be 
modulated by altering the molar ratios of the two monomers. Injectable PLGA spheres were used 
to deliver stem cells and it was found that pre-differentiating stem cells attached to the PLGA 
spheres improved the adipose tissue formation in vivo.20-23 In a different model of adipose tissue 
formation, PLGA was loaded in closed chambers incorporating a vascular pedicle for 
angiogenesis but researchers mainly observed granulation and fibrous tissue formation.24,25 
PLGA hollow fibers were also used for formation of cell aggregates and adipogenic 
differentiation of stem cells showing cells could persist in the hollow fibers in vivo.26 Other 
groups have also used solid forms of PLGA scaffolds where cells are seeded directly on the 
scaffold and differentiated towards adipogenesis before in vivo application.27-31 
In addition to the solid polymer scaffolds previously described, polymers can also take the 
form of a hydrogel. Hydrogels are characterized as water-soluble polymers that can be 
crosslinked to form a hydrogel scaffold that shows high swelling properties in aqueous solutions. 
Polyethylene glycol is a commonly used hydrogel in which cells are typically encapsulated 
within the hydrogel prior to crosslinking. Photopolymerized polyethylene glycol hydrogels 
supported adipogenic differentiation of embryonic32 and adult mesenchymal stem cells33 
although it was found that the addition of bFGF to hydrogel scaffolds greatly improved 
vascularization and cell infiltration in vivo.34 
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2.2.2 Naturally derived scaffolds 
Scaffolds for tissue engineering can also be derived from natural sources and generally have high 
biocompatibility. Some examples of naturally derived biomaterials are alginate, silk and 
chitosan. Alginate is a natural polysaccharide derived from seaweed. Stem cells differentiated 
along the Adipogenic lineage were encapsulated in alginate and implanted subcutaneously.35 To 
render alginate susceptible to degradation, an oxidized form of alginate was also investigated36 
as well as combined collagen alginate microspheres to better mimic the native extracellular 
matrix environment.37 Similar to alginate, chitosan is a natural polysaccharide that is isolated 
from chitin. So far researchers have used it in combination with hyaluronic acid to form an 
injectable hydrogel38 or with PLGA to form a porous scaffold31 for adipose tissue engineering.  
Silk is another naturally derived scaffold that is fibrous in nature and has high mechanical 
strength. In adipose tissue engineering, it has been applied as a scaffold for adipogenic 
differentiation of stem cells and subsequently implanted in rodent models.39-42 The silk scaffolds 
alone produced a fibrous tissue, but when seeded with adipogenic differentiated cells, maintained 
their adipogenic state with lipid-laden cells observed over time. 
2.2.3 Extracellular matrix - based materials 
A subset of naturally derived scaffolds are extracellular matrix-based biomaterials. This includes 
extracted components of the extracellular matrix such as collagen, dextran, fibrin, matrigel and 
hyaluronic acid, as well as bulk extracellular matrix obtained through decellularization 
procedures. These natural ECM-based scaffolds typically have high biocompatibility, and since 
they originate from the matrix, they contain the cell-binding domains required for the survival 
and growth of anchorage-dependent cells. 
Collagen 
Collagen is perhaps the most studied, as it forms the structural basis for much of the extracellular 
matrix of our tissues. Collagen can be used as a scaffold in which cells can be seeded directly on 
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the collagen matrix and differentiated with adipogenic media43,44 Collagen sheets with an elastin 
component have also been tested for adipose engineering, based on a scaffold designed to be a 
skin substitute45 Collagen sponges are a porous form of the collagen based scaffold and provide 
increased surface area and permeability.46,47 A few groups have also incorporated gelatin 
microspheres in the collagen scaffolds for controlled release of bFGF in a collagen sponge48 and 
collagen gel49 to improve adipogenesis. Collagen microparticles or beads have been fabricated 
and used as microcarriers for cell delivery.50,51 In a modified design based on the collagen gel, 
short embedded collagen fibers were incorporated in a collagen gel to improve structural support 
and limit cell-mediated contraction of the constructs.52 
Gelatin 
Gelatin is derived from collagen, typically from bovine sources, and can be used in a number of 
forms similar to collagen. For application in adipose tissue engineering, it has primarily been 
used as a gelatin sponge onto which cells are seeded and differentiated before in vivo 
implantation.19,43,53,54 Gelatin has also been used as microparticles for controlled release of bFGF 
in several systems to aid adipogenesis.48,49,55,56 
Fibrin 
Fibrin is a blood component involved in the clotting process and can be used as a matrix for 
tissue engineering applications. Polymerization of fibrin is initiated with thrombin, and the fibrin 
gel can be naturally degraded in vivo. Fibrin matrices have been used for culture of cells in vitro 
as well as in vivo delivery for stem cells and in conjunction with endothelial cells.50,57-63 One of 
the groups using fibrin matrices has also observed that providing a mechanical support for the 
developing construct greatly enhances generation of new adipose tissues.59,60 
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Hyaluronic acid 
Hyaluronic acid (HA) is a linear polysaccharide and is a natural component of the extracellular 
matrix. Hyaluronic acid can be chemically modified to modulate its material and biological 
properties, making it a popular choice as a biomaterial for tissue engineering. A hyaluronic acid 
sponge fabricated from an ester derivative of hyaluronic acid allowed evaluation of the 
adipogenic potential for sponges with varying pore sizes and degrees of esterification.64-66 In 
another formulation, a hyaluronic acid gel was formed with varying degrees of amidation of 
carboxyl groups and studied for application in adipose tissue engineering.67 The two were 
compared in a study that investigated the in vivo response to the scaffolds alone and found less 
inflammation in the HA gels with dodecyl amidation and improved adipogenesis compared to 
the esterified HA sponges.68 Additionally, cross-linked HA can be used as a hydrogel for 
adipogenesis69 and can be combined with extracts from adipose tissue to improve bioactivity.70 A 
polyethylene glycol- HA composite with encapsulated VEGF in heparin nanoparticles was 
investigated by one group to see if the added growth factor would enhance adipogenesis.71 In a 
different approach to develop a material that can be modulated by physiological signals, a 
chitosan-HA hydrogel was developed for insulin delivery in a glucose responsive hydrogel upon 
swelling.38 Through this design, the scaffold could deliver insulin, an adipo-inductive factor, 
locally after swelling. 
Matrigel 
Some of the most successful cell-free approaches to adipose tissue regeneration use Matrigel, a 
basement membrane extract derived from the EHS sarcoma in a mouse. Researchers found that 
subcutaneous injections of Matrigel with bFGF resulted in de novo adipose tissue formation, 
regardless of the site of injection.72,73 Gelatin microspheres have also been used for controlled 
release of bFGF in Matrigel and were found to be more effective at lower concentrations of 
bFGF compared to doping the bFGF directly in Matrigel.55,56 Other groups have also established 
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a model in which Matrigel and bFGF are enclosed in a chamber in which a vascular pedicle is 
inserted to observe adipogenesis in a closed environment isolated from the surrounding tissue 
such that only circulating cells from the vasculature would contribute to new tissue 
formation.24,74,75 
Tissue based protein extracts 
Extracellular matrix proteins are a promising class of biocompatible scaffold materials since they 
comprise the natural environment for cells in the body. Similar to the approach of extracting 
basement membrane proteins from the EHS sarcoma to produce Matrigel, investigators have also 
explored using different tissues as the starting material to form tissue extracts composed of 
extracellular matrix proteins. Groups have isolated proteins from the adipose matrix in a similar 
preparation to Matrigel, producing a protein extract enriched for adipose matrix components that 
can form a hydrogel at physiological temperature.76,77 Additional tissue-derived protein extracts 
have been produced using dermis,78 skeletal muscle,79 and cardiac muscle.80 Adipose stem cells 
grown on these tissue-derived hydrogels show spontaneous adipogenic differentiation, 
suggesting that bioactive factors from the tissues partition with these extracted components. 
Another group has also incorporated adipose tissue extracts into electrospun nanofibers, showing 
that the nanofibers support stem cell attachment and survival.81 
Bulk decellularized extracellular matrices 
Another class of extracellular matrix-based biomaterials is derived through decellularization of 
bulk tissues to obtain an acellular matrix. Typically tissues are processed with various solvents 
such as detergents, acids, and enzymes to remove the cellular component and prevent 
antigenicity. Lipoaspirate taken from patients undergoing liposuction procedures can be 
decellularized and milled to a powder to produce an injectable adipose ECM powder.82-85 
Adipose ECM powders can be formed into a thermoresponsive hydrogel by acid solubilization 
so that it undergoes gelation upon injection.86 Intact adipose tissue from patients who undergo 
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procedures where bulk tissue is excised, such as abdominoplasty or brachioplasty procedures, 
can also be decellularized to produce an extracellular matrix that remains intact.87,88 This adipose 
extracellular matrix can also be solubilized using pepsin and formulated into microcarrier 
beads89 or foams90 for adipose tissue engineering. Placental tissue has also been decellularized 
and explored as a tissue source for use as a scaffold for adipose tissue regeneration.69,91,92 
2.3 Cell sources  
2.3.1 Cells of adipose tissue 
The parenchymal cells of adipose tissue are adipocytes, terminally differentiated lipid-filled cells 
providing a key energy reserve for the rest of the body. Although they are the primary cells 
transplanted in fat grafting procedures, their inability to replicate, high metabolic demands, and 
fragile nature limit their utility in adipose tissue regeneration. As an alternative, many 
researchers have looked to progenitor cells that can be readily expanded and are capable of 
differentiating into adipocytes. Another prominent cell type in adipose tissue is endothelial cells 
due to the extensive vascularization of adipose tissue. Each adipocyte in the body has immediate 
access to at least one blood vessel, and the processes of adipogenesis and vascularization are 
tightly coupled during development. Endothelial cells have often been used in conjunction with 
adipose stem cells to encourage vascularization of constructs for nutrient diffusion to cells and to 
encourage adipogenesis.37,41,57,62,93 
2.3.2 Adult stem cells 
One of the early sources of adult stem cells to be investigated was bone marrow. A subset of 
multipotent progenitor cells was found to reside in the bone marrow niche and could be induced 
to differentiate down specific mesenchymal lineages.94 The bone marrow aspirate is collected 
from the iliac crest, followed by selection for plastic-adherent cells. 
Adipose-derived stem cells present an intriguing cell population for adipose tissue 
engineering due to the relative ease of access for cell harvesting by liposuction. A resident 
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population of multipotent cells has been identified in the stromal vascular fraction of adipose 
tissue and is likely to be the compartment in which adipocyte precursor cells reside. These 
adipose-derived cells have also been shown to differentiate down multiple mesenchymal 
lineages including adipose, bone, cartilage, neurons, and myocytes. In comparison to mature 
adipocytes, ASCs are easily expanded in culture and have a fibroblastic morphology. When 
exposed to adipogenic induction media, the cells begin to undergo adipogenic differentiation and 
start accumulating lipid. 
The adipose-derived stem cells are typically isolated from adipose tissue by enzymatic 
digestion, generating a heterogeneous cell population of stromal vascular cells. Adipose-derived 
stem cells express many of the mesenchymal stem cell surface markers, including CD 13, CD 
29, CD 44, CD 71, CD 73, CD 90, CD 105, and STRO-1 while being negative for the 
hematopoietic lineage markers CD14, CD16, CD45, CD56, CD61, CD62E, CD104, CD106, and 
endothelial markers CD31 and von Willebrand factor.95 Initially a heterogeneous population of 
stromal vascular cells, selection of the plastic adherent population depletes many cells of 
hematopoietic origin. After in vitro expansion over several passages, cells tend to show 
decreased expression of CD11, CD14, CD34, CD45, CD86, and HLA-DR while becoming 
uniformly positive for the other stromal cell surface markers with successive passages, 
suggesting that a more homogeneous population of cells is established over time.96,97 Continuing 
development of point of care systems to automate stromal vascular cell isolation can potentially 
allow the use of autologous cells for treatment to be widely adopted in the clinic. 
2.3.3 Embryonic stem cells 
Embryonic stem cells are pluripotent cells that have high proliferative capacity in culture and can 
be expanded through far more passages compared to adult stem cells without reaching 
senescence. The cells are isolated from the inner cell mass of blastocysts and can be 
differentiated towards numerous somatic cells with varying phenotypes. The use of embryonic 
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stem cells in research has been fraught with controversy and is subject to political policies that 
can limit access to their use. 
2.3.4 Induced pluripotent stem cells 
In 2006 researchers discovered that it was possible to induce adult somatic cells to revert to an 
embryonic-like state by genetically reprogramming the cells to express the transcription factors 
Oct3/4, Sox 2, and Klf4.98-100 Cells expressing these factors exhibited key characteristics of 
embryonic stem cell pluripotency, including embryoid body and teratoma formation, and proved 
capable of differentiating into cells of all three germ layers. As a result, any adult somatic cell 
may be used as a cell source, thereby circumventing the ethical issues and political influences 
controlling the use of embryonic stem cells in research. 
IPS cells have been successfully differentiated down the adipogenic lineage showing similar 
efficacy as embryonic stem cells for adipogenic differentiation.101 Thus far, the use of iPS cells 
in adipose tissue engineering has been limited, and consistent directed differentiation of cell 
populations still remains a challenge.  
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3. Development of an Adipose Matrix – Based Biomaterial 
3.1 Introduction 
There is a significant need for soft tissue replacements in the field of reconstructive surgery. 
Autologous tissue is currently the treatment of choice for repairing soft tissue defects due to 
trauma, tumor resection, and congenital defects.4,102,103 However, current autologous fat transfer 
techniques have a number of limitations. For many HIV patients suffering from lipodystrophy 
and patients undergoing chemotherapy for cancer, the associated cachexia leaves them without 
the adipose volume required for autologous tissue transfer. Additionally, the persistence of fat 
transfer varies widely and is often surgeon, technique, and patient dependent.  With resorption 
causing up to 40-55% reduction of total graft volume over six months, multiple procedures are 
often required in order to maintain the desired correction and volume limitations need to be 
taken into account to prevent necrosis.104 Finally, implanted adipose tissue can lead to post-
operative calcifications which is detrimental to patients with a history of breast cancer as this 
may interfere with early radiologic detection of cancer.105  
Developments in plastic surgery and microsurgical techniques have established autologous 
tissue flaps as excellent options for post-mastectomy breast reconstruction, offering patients 
outstanding aesthetic outcomes without the concern for long-term alloplastic implant 
complications such as capsular contracture and rupture.4,13 However, a complex procedure like 
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autologous flap transplantation carries its own set of risks including necrosis of transplanted 
tissue106 and donor site morbidity, such as abdominal wall weakness, scarring, and hernia.4,107-109 
Perforator flap techniques and new imaging protocols have been developed to help leave the 
musculature intact in order to decrease donor site morbidity; nevertheless, they remain complex 
and lengthy undertakings.11,110-113  
Regenerative medicine approaches to soft tissue reconstruction provide a potential 
alternative in which biomaterials facilitate tissue regeneration in the defect area, thus avoiding 
the need for tissue transplantation from a donor site. Several studies have investigated the use of 
various synthetic polymers in conjunction with a cell delivery using polyethylene glycol, poly L-
lactic acid, polyglycolic acid, and poly(lactic-co-glycolic) acid copolymers.15,21,22,26,27,29,32,33,59,114 
Naturally-derived polymer scaffolds such as collagen, hyaluronic acid, gelatin, silk fibroin, 
alginate, and fibrin have also been applied to adipose tissue engineering.35,42,48,61,65-67,115 
Additionally, researchers have tried to harness extracellular matrix (ECM) components for use in 
adipose tissue engineering using ECM derived from EHS sarcomas (Matrigel), adipose tissue, 
dermis, muscle, and placenta. 55,72,75,76,79,83,91,92,116,117 However, a recent review highlights the lack 
of three-dimensional scaffolds derived from adipose tissue.118 
Here we show the development of a novel adipose-derived extracellular matrix biomaterial 
that serves as a three-dimensional scaffold for tissue regeneration. Intact ECM-based 
biomaterials have not been previously studied in vivo for use as a volume-stable soft tissue 
implant that can be crosslinked to control degradation properties.118,119 We hypothesized that 
intact human adipose tissue could be decellularized to obtain a matrix that would provide an 
instructive environment for the repair of soft tissue defects. To control the rate of degradation, 
chemical crosslinkers can be used to reinforce the collagen and other proteins in matrix-based 
scaffolds. Thus, the aims of this study are to develop a biocompatible adipose-derived 
biomaterial by removing lipids and resident cells from adipose tissue, use crosslinkers to 
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modulate degradation properties of the extracellular matrix, and evaluate the biocompatibility of 
the matrix in vivo. 
3.2 Materials and Methods 
Adipose extracellular matrix was produced by decellularizing adipose tissue using a combination 
of mechanical and chemical processing steps. Upon obtaining the acellular adipose tissue, the 
material was characterized, before being crosslinked to modulate degradation profiles. In vitro 
and in vivo biocompatibility studies were performed to investigate the cell and tissue response to 
the adipose-derived biomaterial. Materials were obtained from Sigma-Aldrich (St. Louis, MO) 
unless otherwise noted. 
3.2.1 Adipose extracellular matrix preparation 
Subcutaneous adipose tissue was subjected to mechanical processing and extensive rinsing 
which was followed by incubation with 0.1%, 1%, 3%, or 5% peracetic acid for 3 hours to 
remove cells. Samples were brought back to physiological pH using PBS and incubated 
overnight with 1% Triton X-100 in 2 mM EDTA to remove residual lipids. Finally, samples 
were treated with 600 U/mL DNase (Roche, Indianapolis, IN) in 10 mM MgCl2 overnight at 
37°C.  
3.2.2 Material characterization 
Biochemical assays 
Adipose ECM scaffolds were lyophilized and digested in a 125 ug/mL papainase solution 
(Worthington) for 16 hours at 60°C. DNA content was determined by fluorescence intensity 
using 1 ug/mL Hoechst dye (Molecular Probes, Eugene, OR) in TNE buffer.120 Total collagen 
content was determined by a hydroxyproline assay with acid hydrolysis in 6N hydrochloric acid 
at 115°C, followed by reaction with p-dimetylaminobenzaldehyde and chloramine-T hydrate to 
obtain an absorbance reading at 525 nm.121  
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Scanning electron microscopy (SEM) 
Samples were prepared for SEM by fixing in 3.0% formaldehyde/1.5% glutaraldehyde in 0.1 M 
sodium cacodylate buffer with 2.5% sucrose for 1 hour. Samples were then post-fixed with 1% 
osmium tetroxide for 30 minutes before dehydration with graded ethanol solutions. Samples 
were dried using CO2 critical point drying, which was followed by sputter-coating with platinum 
and imaging with a FEI Quanta 200 SEM (Hillsboro, OR). 
Proteomic analysis 
Adipose extracellular matrix samples were prepared for mass spectrometry analysis by 
cryomilling (SPEX Sample Prep, Metuchen, NJ) and solubilizing in 4 M guanidine HCl and 50 
mM sodium acetate at pH 5.8 with vortexing for 48 hours. 100 ug of protein quantified with the 
BCA assay was moved to a new eppendorf tube and diluted down to 0.5 M guanidine HCl using 
distilled water. Samples were reduced by adding 2 ul of 50 mM TCEP, incubated at 37°C with 
vortexing for one hour, alkylated by adding 1 ul of 0.1 M MMTS, and incubated at room 
temperature for 15 minutes. Deglycosylation was carried out using 5 ul of deglycosylation 
enzyme mix (New England Biolabs, Ipswich, MA), which includes 500,000 U/ml PNGaseF, 
40,000,000 U/ml O-Glycosidase, 50,000 U/ml Neuraminidase, 8,000 U/ml β1-4 Galactosidase, 
and 4,000 U/ml β-N-acetylglucosaminidase. Samples were incubated at 37°C for 4 hours to 
complete deglycosylation. Samples were digested overnight with trypsin (Promega) at a 1:50 
ratio and maintained at 37°C with vortexing. In the morning a second aliquot of trypsin at a 1:50 
ratio was added and samples were incubated at 37°C for an additional 4 hours.  
For 1D SDS-PAGE gels, protein samples were boiled with Laemmli sample buffer (Bio-
Rad) containing β-mercaptoethanol for 10 minutes at 100°C. Samples were loaded on Criterion 
4-20% Tris-HCl gels (Biorad) and run for 50 minutes at 200 volts on a Criterion Cell (Bio-Rad). 
Protein bands were visualized with silver staining (Thermo Scientific Pierce).  
     17
 
Protein identification by liquid chromatography tandem mass spectrometry (LCMS/MS) 
analysis of peptides was performed using an LTQ Orbitrap Velos MS (Thermo Scientific) 
interfaced with a 2D nanoLC system (Eksigent). Peptides were fractionated by reverse‐phase 
HPLC on a 75 um x 10 cm PicoFrit column with a 15 um emitter (PF3360‐75‐15‐N‐5, New 
Objective) in‐house packed with Magic C18AQ ( 5 μm, 120Å, Michrom) using 1‐45% 
acetonitrile/0.1% formic acid gradient over 90 min at 300 nl/min. Eluting peptides were sprayed 
directly into an LTQ Orbitrap Velos at 2.0 kV. Survey scans (full ms) were acquired from 
350‐1800 m/z with up to 10 peptide masses (precursor ions) individually isolated with a 1.2 Da 
window and fragmented (MS/MS) using a collision energy of HCD35, 30s dynamic exclusion. 
Precursor and the fragment ions were analyzed at 30,000 and 15,000 resolution, respectively. 
Peptide sequences were identified from isotopically resolved masses in MS and MS/MS spectra 
and searched against all human entries in RefSeq 2012, with oxidation on M, 
carbamidomethylation on C and Mascot Daemon (Matrix Science) software. Mass tolerances on 
precursor and fragment masses were 10 ppm and 0.03 Da, respectively. Mascot search result 
files were processed in Scaffold (Proteome Software) or Proteome Discoverer to validate protein 
and peptide identifications. 
Differential Scanning Calorimetry 
Differential scanning calorimetry was carried out using a DSC 8500 (Perkin Elmer) to determine 
the thermal properties of the adipose matrix through the different processing steps and determine 
whether the terminal sterilization process of gamma irradiation has a detrimental impact on the 
collagen structure. Hydrated samples between 3-10 mg were loaded onto sample pans and 
hermetically sealed. The endotherm was measured against an empty reference pan from -20°C to 
95°C at a rate of 5° per minute with two heating cycles per sample.  
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Rheology 
The rheological properties were tested using an ARES-G2 Rheometer (TA Instruments). 1 ml 
samples were loaded onto 25 mm parallel plate fixtures with the gap set to 1.0 mm for each run. 
A strain sweep was run at frequencies of 0.1, 1, 10, 100 rad/s and the strain percent for 
subsequent runs were set based on the linear viscoelastic region. Dynamic frequency oscillation 
measurements were taken over an angular frequency range of 0.1 to 100 rad/s to determine the 
storage modulus and complex viscosity.  
3.2.3 Crosslinking 
Crosslinking of adipose extracellular matrix 
Adipose ECM was crosslinked using 1-Ethyl-3-(-3-dimethylaminopropyl) carbodiimide  
hydrochloride (EDC) and N-hydroxysuccinimide (NHS) in 50 mM 2-(N-morpholino) 
ethanesulfonic acid buffer at pH 5.5.122 Samples were incubated with crosslinking solutions for 4 
hours at concentrations of 5, 10, 50, and 100 mM EDC with an EDC:NHS molar ratio of 2:1. 
Residual crosslinkers were removed by rinsing with 0.1M Na2HPO4 for 2 hours followed by four 
additional 30 minute incubations with distilled water.  
EDC crosslinking was compared with hexamethylene diisocyanate (HMDC). Due to its 
instability in aqueous solutions, previous studies have used secondary alcohols as the solvent or 
used surfactants to preserve HMDC reactivity.123,124 For the secondary alcohol suspension, 1% 
and 5% HMDC solutions were dissolved in 2-propanol and samples crosslinked for 4 hours. 
Alternatively, samples were crosslinked with 1% and 5% HMDC in a surfactant solution 
containing 1% Tween 20 in a phosphate buffer (0.054 M Na2HPO3, 0.013 M NaH2PO4) at pH 
7.4 for 4 hours. Residual crosslinkers and surfactant were removed with distilled water rinses.  
Resistance to enzymatic degradation 
The crosslinking conditions were characterized by comparing susceptibility to enzymatic 
degradation. Crosslinked samples and uncrosslinked controls (n=3) were lyophilized and 
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incubated with 200 U/mL collagenase I in 0.05 M Tris-HCl (pH 7.5) at 37°C.123,125 At timepoints 
of 1, 3, 8, 16, and 24 hours, the samples were spun down and supernatants collected and stored at 
-20°C until completion of the experiment and fresh collagenase added to samples. At 24 hours, 
any remaining ECM was digested with papainase. Finally, the supernatants and papain digested 
samples were analyzed via the collagen assay to quantify solubilized collagen. The percentage of 
total collagen degraded was calculated at the different timepoints. 
3.3 Results 
3.3.1 Adipose extracellular matrix  
We obtained an acellular adipose-derived matrix that retains properties from adipose tissue for 
soft tissue repair. The processing methods developed for decellularizing adipose tissue resulted 
in significant macroscopic changes as lipids and other cell components were removed. 
Intracellular lipids contribute to the characteristic yellow color of intact adipose tissue and as the 
lipids are removed, the ECM remains as a white fibrous tissue scaffold (Fig 3.1). Histological 
analysis revealed the complete removal of nuclei and the absence of intracellular lipid vacuoles 
characteristic of adipose tissue. Immunostaining for collagen I confirms it as the predominant 
component of adipose ECM.  
 
 
Figure 3.1 Processed adipose tissue matrix. Processed adipose tissue matrix (A) and histological 
image of decellularized adipose tissue showing no remnants of cell nuclei (B). Immunostaining for 
type I collagen confirms it as the predominant component of adipose extracellular matrix (C). 
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3.3.2 Material characterization 
Various processing conditions were compared to determine the optimal processing scheme to 
decellularize adipose tissue. Biochemical analysis of the composition of adipose scaffolds 
showed little donor variability across the three different donors. Samples treated with 0.1% 
peracetic acid had the highest DNA content in comparison with samples from higher acid 
concentrations and also showed incomplete lipid removal as evidenced by residual yellow lipids 
in the tissue.  
Collagen content in the ECM decreased at higher peracetic acid concentrations, most 
notably with 5% peracetic acid. The optimal processing condition was determined by the ability 
to best satisfy the two goals of completely removing cellular material while preserving 
extracellular matrix structure. Ultimately, 3% peracetic acid was determined to give optimal 
results and was used for subsequent experiments.  
SEM images of the decellularized adipose matrix show the fibrillar structure of the ECM 
with bundles of varying thickness (Fig 3.2). The ECM is porous in nature, facilitating cell 
migration and nutrient diffusion. In vitro experiments with ASCs reveal extensive cell adhesion 
and spreading on the ECM of the decellularized tissue. Multiple cell-ECM contacts can be seen 
for each cell by day 7 in culture.  
 
Figure 3.2 Scanning electron microscopy images of adipose ECM without cells (A) and 48 hours 
after seeding with cells (B). 
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Proteomic analysis 
To identify the protein composition of the adipose extracellular matrix and determine tissue-
specific differences between adipose and dermal extracellular matrices, samples were solubilized 
with an organic solvent prior to reduction and alkylation. Deglycosylation was also adapted to 
improve enzyme access for the digestion and samples were digested overnight in trypsin to 
obtain peptides for identification with mass spectrometry. After carrying out liquid 
chromatography tandem mass spectrometry (LC-MS/MS), the resulting spectra were searched 
against a database of the human proteome to identify the proteins they originate from, and were 
classified based on the matrisome proteins as defined by Naba et al.126 The 1D SDS-PAGE gel of 
the solubilized proteins show different bands when comparing the adipose and dermis samples,  
and deglycosylation changes the migration of proteins as the sugars are cleaved (Fig 3.3A). After 
the overnight trypsin digestion, we were able to obtain a complete digestion with most of the 
bands no longer visible as the tryptic peptides run off the gel (Fig 3.3B)  
Proteomic analysis with LC-MS/MS identified a total of 25 proteins corresponding to the 
matrisome or matrisome-associated proteins (Fig 3.4). There was some contamination from 
residual intracellular proteins such as cytoskeletal proteins. There were 11 proteins shared in 
common between the adipose and dermal matrix, 1 protein unique to the dermis, and 13 unique 
to adipose tissue. When observing the breakdown by the number of peptides contributing to each 
category of proteins, peptides belonging to the collagen family dominate the spectra for both 
dermal and adipose tissues since they are a primary structural component of the ECM. 
Proteoglycans also had good coverage for both tissues. There were very few ECM glycoproteins 
identified in dermis compared to adipose and ECM-affiliated proteins were identified only in 
adipose tissues.  
 




Figure 3.3 1D SDS-PAGE gels of the adipose extracellular matrix and acellular dermis. Samples 
from two separate donors (Adip 1, Adip 2) with technical replicates (Adip 1.1, Adip 1.2) solubilized 
with guanidine HCl and deglycosylated (A). After trypsin digestion the bands are no longer visible 
(B).  
 




Figure 3.4 Proteomic characterization of the adipose and dermis ECM by LC-MS/MS. Shared and 
unique proteins for adipose and dermis ECM (A) Distribution by number of peptides corresponding 
to the matrix protein categories (B). List of the proteins and their classifications and number of 
peptides identifying them (C). 
 
Most of the collagens were shared between the two tissues (Collagen types I, III, VI) with 
type XIV found only in adipose tissue. Most proteoglycans, including biglycan, decorin, lumican 
osteoglycin and prolargin, were also common to both tissues. The two proteoglycans detected 
only in adipose tissues were aspirin and heparin sulfate. ECM glycoproteins and ECM-affiliated 
proteins were differentially expressed in the two tissues; this is where most differences were 
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observed. Most ECM glycoproteins, including cartilage intermediate layer protein, 
dermatopontin, fibrillin, and laminin, were found only in adipose tissues, while the single protein 
unique to dermis was the ECM glycoprotein periostin. ECM-affiliated proteins that were 
observed in adipose tissues were annexins A1, A2, and A6 and coagulation factor XIII, while no 
ECM-affiliated proteins were detected in dermis.  
Differential Scanning Calorimetry 
The thermal stability of the adipose matrix through the different stages of processing for 
lipid removal and decellularization were determined using DSC (Fig 3.5). The endotherm for 
intact adipose tissue shows two characteristic peaks at around 7°C and 32°C, most likely 
attributed to phase changes of the lipids. Adipose samples immediately after pressing for lipid 
removal show the characteristic peak at around 66°C, typical of collagen based materials where 
the peak corresponds to the denaturation temperature of the collagen. It is an irreversible process 
and so the peak is no longer observed during the second heating cycle. With peracetic acid 
treatment, there is a slight negative shift of a few degrees to around 64°C. The denaturation 
temperature does not change significantly with incubation using the detergent Triton X-100, but 
with gamma irradiation there is a larger negative shift down to 57°C, indicating slight weakening 
of the collagen structure with irradiation for terminal sterilization (Table 3.1). 
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Figure 3.5 DSC thermogram of the adipose ECM through the processing stages. 
 
Table 3.1Denaturation peak temperature 
Sample Peaks (°C) 
Gamma irradiated 57.23 ± 0.48 
Triton X-100 63.53 ± 0.48 
Peracetic Acid 63.99 ± 0.21 
Pressed 66.37 ± 0.48 
Adipose Tissue 7.35 ± 0.35, 32.29 ± 0.05 
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 Rheology 
Rheological testing was carried out to compare the viscoelastic properties of the adipose matrix 
with current clinical options of lipoaspirate and the dermal fillers calcium hydroxyapatite 
(Radiesse) and crosslinked hyaluronic acid (Juvederm). The storage modulus of Juvederm was 
the lowest over all the frequencies tested. Lipoaspirate had a slightly lower storage modulus than 
adipose ECM but both materials stayed fairly constant over the frequency range tested and were 
nearly parallel throughout. Radiesse started with a lower storage modulus than lipoaspirate, but 
quickly increased with increasing angular frequency. The sharper rise in the storage modulus 
resulted in Radiesse having the highest storage modulus at frequencies above 2 rad/s (Fig 3.6A).  
Juvederm also had the lowest complex viscosity of all the materials tested, making it easiest 
to undergo deformation. Adipose ECM again had a slightly higher complex viscosity compared 
to lipoaspirate, but both had similar rates of decrease in complex viscosity with increasing 
angular frequency. Radiesse started with a similar complex viscosity modulus as lipoaspirate at 
the lowest frequencies, but showed a slower rate of decrease in complex viscosity with 
increasing frequencies and ended up surpassing both lipoaspirate and adipose ECM at around 1 
rad/s to end up with the highest viscosity modulus at higher frequencies (Fig 3.6B).  
3.3.3 Crosslinking  
To control the degradation of the ECM, different chemical crosslinking methods were compared. 
EDC-crosslinked samples showed greater resistance to enzymatic degradation in comparison to 
uncrosslinked controls when incubated with collagenase (Fig 3.7). Resistance to degradation 
increased with higher concentrations of the chemical crosslinker. HMDC crosslinking resulted in 
different degradation profiles depending on the solvent used. For samples reacted in Tween 20, 
very little degradation was observed with no differences between 1%-5% HMDC concentrations, 
whereas HMDC in 2-propanol showed greater resistance to enzymatic degradation for 5% 
HMDC samples compared to 1% HMDC. 




Figure 3.6 Mechanical properties of the adipose ECM and commercial fillers. Rheological testing of 
the adipose ECM, lipoaspirate, and commercial dermal fillers Radiesse (calcium hydroxyapatite) 
and Juvederm (crosslinked hyaluronic acid) gives measures of the storage modulus (A) and complex 
viscosity (B). 
 




Figure 3.7 Crosslinked matrices show increased resistance to enzymatic degradation. Percent of 
total collagen degraded over 24 hours when incubated with collagenase for uncrosslinked control 
tissue and matrices crosslinked with 5-100 mM EDC (A), 1% and 5% HMDC in Tween 20 (B), 1% 
and 5% HMDC in 2-propanol (C). Error bars denote standard deviation. 
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3.4 Discussion 
Decellularization of tissues has become increasingly popular as a method to obtain a matrix of 
proteins and sugars ideally suited to direct the migration of cells into the matrix and provide the 
structural cues to maintain cell survival.127 A range of applications has been explored for 
decellularized ECM derived from dermal, cardiovascular, musculoskeletal, hepatic, and 
gastrointestinal tissues, many of which are already in clinical use and have been shown to 
facilitate tissue integration and restoration.128  
Our studies showed that a decellularized ECM biomaterial can be derived from adipose 
tissue to obtain a biocompatible scaffold for the repair of soft tissue defects. Proteomic analysis 
of the adipose matrix and acellular dermis identified a number of glycoproteins and ECM 
affiliated proteins that were unique to the adipose ECM. The annexins are a class of proteins 
found only in the adipose matrix. Annexin A1 is a mediator of the inflammatory response with 
anti-inflammatory properties that prevent recruitment and migration of leukocytes while 
Annexin A2 has been found to show antithrombogenic activity.129 For the glycoproteins, 
dermatopontin is a widely studied protein with known functions in ECM assembly, cell 
adhesion, and modulation of TGF-β1 activity.130 Fibrillin is a glycoprotein important in the 
formation of microfibrils which form elastin fibers and store TGF-β1.131,132 Laminin is a critical 
component of the basement membrane, affecting cell movement, differentiation, shape, and 
survival.133 The proteomic analysis provided a comprehensive protein profile for the extracellular 
matrices of the different tissues. Tissue specific differences were prevalent, even between two 
closely related connective tissues, adipose and dermis.  
Thermal analysis of the adipose matrix showed slight changes in the structure through the 
different processing stages using differential scanning calorimetry, a method sensitive enough to 
capture changes in the molecular stability of collagen-based materials. Collagen undergoes 
irreversible denaturation with heating, undergoing a conformational change from the triple 
helical structure to a random coil state due to disruption of the intramolecular crosslinks. For 
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both the peracetic acid and gamma irradiation steps, a negative shift of the collagen denaturation 
peak was observed. This suggests that the structure is slightly weakened by these processes. Acid 
treatment likely solubilizes a number of proteins and proteoglycans from the matrix, reducing its 
structural stability as well as altering its hydration state. Gamma irradiation has been found to 
cause oxidative damage to collagen structure by disrupting crosslinks and causing fragmentation 
by peptide scission.134-137 For products intended for clinical use, terminal sterilization methods 
are one of the precautionary steps often taken to ensure minimal bioburden, but must be balanced 
against the possible structural damage from the irradiation.  
Rheological analysis of the adipose matrix, lipoaspirate, and commercial dermal fillers 
demonstrate the range of mechanical properties for the different products. For the commercial 
fillers, crosslinked hyaluronic acid (Juvederm) had the weakest viscoelastic properties while 
calcium hydroxyapatite (Radiesse) had the highest storage modulus and complex viscosity for 
the majority of frequencies tested. Human adipose ECM and lipoaspirate were positioned 
between the two, with adipose ECM having a slightly higher storage modulus and complex 
viscosity, and having similar rates of change in their respective moduli with change in angular 
frequencies. This suggests that many of the mechanical properties of the original tissue are 
retained in the adipose ECM and the viscoelastic behavior of the matrix was most similar to 
lipoaspirate across the range of frequencies tested. Calcium hydroxyapatite proved to be most 
resistant to deformation, with the greatest increase in storage modulus and most gradual decrease 
in complex viscosity with increasing frequencies. Alternatively, crosslinked hyaluronic acid was 
the most susceptible to deformation. Based on the mechanical properties, the adipose matrix is a 
suitable filler for soft tissue defects due to the similarity in viscoelastic properties with the 
surrounding tissue. 
Crosslinking the decellularized scaffold provided an additional element of control over the 
degradation properties of the tissue and allows the material to be tailored to the target site of 
implantation, which may be subject to different mechanical forces. Additionally, the degradation 
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rate can be tuned to the rate of host tissue regeneration to ensure that the biomaterial provides 
sufficient structural support until newly developed tissues repopulate the scaffold. Resistance to 
enzymatic degradation is critical when using natural ECM-based scaffolds since host cells can 
easily degrade the proteins with various endogenous matrix metalloproteinases.   
As our understanding of the role of the extracellular matrix in tissue and organ development 
expands, it is clear that matrix components do not just serve a structural role in tissue, but also 
actively participate in the instructional aspect of cell development. Much has recently been 
elucidated about the role of the various ECM degradation components in influencing cell 
migration and proliferation, particularly in aiding tissue regeneration.138-140 Studies of adipose 
tissue ECM proteins have also shown that they facilitate in vivo adipogenesis.76 In view of this 
instructional role for the ECM, we demonstrated that adipose tissue can be successfully 
processed to remove inflammatory lipids and cells to produce a biomaterial for soft tissue 
reconstruction.  
The components of the adipose-derived scaffold are all naturally occurring ECM proteins 
and proteoglycans that are highly conserved between different species, such that cells are not 
exposed to any materials or synthetic polymers that can induce a foreign body response. Host 
tissue integration is also enhanced since matrix components can be readily degraded by cell-
secreted enzymes as tissue remodeling takes place. Mechanisms for matrix turnover are already 
established in host cells, avoiding any concerns over proper clearance of scaffold materials from 
the body. These factors contribute to the biocompatibility of ECM-based scaffolds and highlight 
their utility in regenerative medicine. 
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4. In Vitro Bioactivity of the Adipose Extracellular Matrix 
4.1 Introduction 
Soft tissue repair remains a challenge for surgeons who have limited options for 
reconstructing areas of soft tissue loss or disfigurement. Ablative surgeries for tumor removal, 
traumatic injuries, and congenital defects all require reconstructive procedures to restore contour 
and symmetry.  Current clinical strategies often require autologous tissue for flap reconstructions 
or fat grafting to fill defects. Surgeons are making strides in developing new reconstructive 
procedures to minimize donor site morbidity, but these approaches still suffer from the key 
drawback that they inherently require donor site tissue, which is limited by availability. Since the 
requirement of autologous tissue  results in donor site morbidities, the procedure essentially 
creates a second defect site to repair the first.141 Additionally, transplanted tissue can have 
complications including necrosis, infection, thrombosis, and hematoma formation.12 These 
complications can lead to total flap loss or unpredictable rates of resorption for fat grafts. This 
predicament highlights the utility and advantages of an off-the-shelf alternative that can fill soft 
tissue defects while promoting soft tissue regeneration.  
Approaches to engineer soft connective tissues traditionally involve choosing a scaffold, 
seeding it with cells, differentiating those cells towards adipogenesis, and finally using the 
construct as a soft tissue replacement. Adipose tissue constructs can be formed by seeding cells 
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on synthetic scaffolds like poly glycolic acid15,16 or encapsulating cells in polyethylene glycol 
hydrogels.32,33 Naturally derived scaffolds can also be used for adipose tissue formation such as 
silk,39,41,42 alginate,35,37 collagen,43,52 and hyaluronic acid.65,67 Adipose extracellular matrix based 
approaches to replacing damaged soft connective tissue have also been explored. Decellularized 
lipoaspirate has been reformed into microcarriers and sponges to provide a substrate for cell 
growth,84,85 and adipose tissue has also been decellularized and fabricated into porous foams for 
adipogenesis.90  
The use of the extracellular matrix as the basis of a biomaterial scaffold is promising due to 
the bioactive properties of the extracellular matrix and its critical role in maintaining cell 
functions in vivo. For the following studies, we wanted to investigate the bioactive properties of 
the adipose matrix for both cell migration and differentiation, as well as the tissue specificity of 
the extracellular matrices when comparing scaffolds derived from different tissue sources. We 
decided to compare the adipose matrix with acellular dermis since it is also a connective tissue 
and is currently available for clinical use.  
4.2 Materials and Methods 
Materials were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
4.2.1 Adipose extracellular matrix preparation 
Subcutaneous adipose tissue was subjected to mechanical processing and extensive rinsing 
followed by incubation with 0.1%, 1%, 3%, or 5% peracetic acid for 3 hours to remove cells. 
Samples were brought back to physiological pH using PBS and incubated overnight with 1% 
Triton X-100 in 2 mM EDTA to remove residual lipids. Finally, samples were treated with 600 
U/mL DNase (Roche, Indianapolis, IN) in 10 mM MgCl2 overnight at 37°C. 
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4.2.2 Adipose-derived stem cell isolation 
Subcutaneous adipose tissue was obtained from patients undergoing abdominoplasty procedures 
with approval from Johns Hopkins Medicine Institutional Review Board. Adipose-derived stem 
cells (ASCs) were isolated by digestion with 1 mg/mL collagenase I (Worthington) in DMEM F-
12 (Gibco) for 1.5 hours on an orbital shaker at 37°C. The resulting cell suspension was 
centrifuged and filtered through 70 uM and 40 uM cell strainers. ASCs were seeded at 5,000 
cells/cm2 and cultured in DMEM-F12 supplemented with 10% fetal bovine serum (Thermo 
Scientific HyClone). Cells were used between passages 3-5 for all studies.  
4.2.3 In vitro cell studies  
Cell viability on crosslinked matrices 
To evaluate cell viability on the crosslinked matrices, cells were seeded on the scaffolds and 
cultured for 5 days in ASC maintenance media (DMEM-F12, 10% FBS, 100 U/mL penicillin, 10 
ug/mL streptomycin). Cell viability was assessed using a LIVE/DEAD Viability/Cytotoxicity 
Kit (Invitrogen, Carlsbad, CA). Cell-ECM scaffolds were incubated with 1 uM calcein AM and 
4 uM ethidium homodimer-1 in DMEM-F12 for 30 minutes at 37°C to visualize live and dead 
cells.  
Migration assay 
Adipose-derived stem cells were serum starved for 24 hours. Cells were trypsinized and seeded 
in the top chamber of a 6.5mm 7.0 um pore size polystyrene transwell (Corning) at 30,000 cells 
per transwell. The adipose extracellular matrix was added to the media in the bottom chamber at 
0, 1, and 10 ug/ml. A positive control of 10% FBS in media was used. Migrated cells were 
quantified after 6 hours using ImageJ (NIH).  
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Adipogenic differentiation of cells in 2D culture on the adipose matrices 
Adipose extracellular matrix was embedded in OCT and cryosectioned at 200 um sections and 
collected on a plus charge coated glass slide. OCT was removed by incubating slides in PBS on 
an orbital shaker with three changes each at 1 hour intervals. Adipose-derived stem cells were 
seeded directly on the adipose matrix on slides or on empty glass slides and cultured in ASC 
expansion media or adipogenic media.  
Adipogenic differentiation was carried out for ASCs seeded on the matrix with adipogenic 
induction media (1 µM dexamethasone, 200 µM indomethacin, 500 µM methylisobutylxanthine, 
10 µg/ml insulin, 1% penicillin/streptomycin, and 10% FBS in High Glucose DMEM). Cells 
were differentiated for 7 days in culture before fixation for histological analysis. Slides were 
fixed for 10 minutes in 10% formalin and stained with Texas Red-phalloidin (Invitrogen) for 
actin, Nile Red for lipids, and rabbit anti-collagen type I antibodies (Fitzgerald) followed by 
FITC- AffiniPure goat anti rabbit IgG secondary antibodies (Jackson) for visualization of the 
ECM scaffold and coverslipped with Vectashield plus DAPI (Vector Labs).  
Adipogenic differentiation of cells in 3D constructs comparing the adipose and dermis ECM 
To evaluate adipogenesis of the cells in a 3D environment and to determine if there is any tissue 
specificity of the extracellular matrices, adipose-derived stem cells were resuspended in 50 ul of 
cryomilled adipose ECM or reconstituted micronized acellular dermis (Cymetra) at 2 million 
cells per construct and seeded in the top chamber of a 6.5 mm transwell (Corning). After 
culturing in ASC expansion media for 48 hours, the constructs were removed from the transwells 
and moved to a 24 well plate. The constructs were cultured on an orbital shaker with adipogenic 
induction media for an additional 15 days.  
For histological analysis, constructs were fixed in 10% formalin overnight, infiltrated with 
sucrose, and embedded in OCT. Samples were cryosectioned at 10 um sections and stained with 
hematoxylin and eosin or Oil Red O for lipid accumulation.  
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RT-PCR 
Samples for determining gene expression levels were snap frozen in liquid nitrogen and crushed 
with a mortar and pestle under liquid nitrogen. Homogenized samples were immediately placed 
in Trizol Reagent (Invitrogen) and total RNA extraction was carried out according to 
manufacturer instructions with the addition of 1 ug of glycogen added to each sample to aid in 
RNA precipitation and phase separation carried out by centrifugation in phase lock gel tubes 
(heavy, 5 PRIME). RNA was resuspended in DEPC water and quantified using a Nanodrop 
(Thermo Scientific). 
cDNA was synthesized using the SuperScript RT III system (Invitrogen) according to 
manufacturer instructions and RT-PCR was carried out with Power SYBR Green (Applied 
Biosystems) on an Applied Biosystems 7500 Real-Time PCR System. Each PCR reaction was 
carried out in triplicate with three biological replicates. Relative quantitation was done using the 
∆∆Ct method142 with beta actin as the housekeeping gene with normalization to day 3 acellular 
dermis data. Primer sequences for adipogenic genes are listed in Table 1.1.   
Table 4.1 RT-PCR Primer sequences  
Gene Forward Sequence 5’ – 3’ Reverse Sequence 5’ – 3’ 
PPARG AGGAGAAGCTGTTGGCGGAGA TGCTTTGGTCAGCGGGAAGG 
LPL GTCAGAGCCAAAAGAAGCAGCAA GGGTTTCACTCTCAGTCCCAGAA 
LEP TGACACCAAAACCCTCATCAAGACAA GGAGCCCAGGAATGAAGTCCAA 
CEBPA TCACCGCTCCAATGCCTACTG CCTGCTCCCCTCCTTCTCTCAT 
FABP4 (ap2) ACAGGAAAGTCAAGAGCACCATAACC TGACGCATTCCACCACCAGTTT 
BACT GGCACCCAGCACAATGAA GCTAACAGTCCGCCTAGAAGC 
HUVEC tube formation assay 
Human endothelial cells (HUVECs) were used to evaluate network tube formation on a 
basement membrane extract.143 HUVECs (Lonza) were cultured in EGM-2 media (Lonza) and 
passaged before reaching confluence. HUVECs were used between passages 2-4 for all studies. 
To analyze HUVEC tube formation in basal media, 30,000 cells were seeded on growth factor 
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Reduced Matrigel (BD) in a 96 well plate and cultured in EBM (Lonza) with adipose ECM at 
concentrations of 0, 0.01, 0.1, 1 mg/ml. For HUVEC tube formation in growth media, 10,000 
cells were seeded on growth factor reduced Matrigel per well of a 96 well plate and cultured in 
EGM-2 with adipose ECM added at concentrations of 0, 0.01, 0.1, 1 mg/ml. After 6 hours in 
culture, cells were imaged with brightfield microscopy and branching was quantified with the 
Angiogenesis Analyzer (written by Gilles Carpentier, 2012. The macro is available at 
http://imagej.nih.gov/ij/macros/toolsets/Angiogenesis%20Analyzer.txt) for ImageJ (NIH). 
4.3 Results 
4.3.1 Cell viability on cross-linked matrices 
Adipose-derived stem cells cultured on the crosslinked adipose extracellular matrices adhered 
and spread on the scaffold and showed good viability when stained with calcein AM and 
ethidium homodimer-1 (Fig 4.1). The adipose matrix supported cell survival with few cells 
staining red to indicate non viable cells.  
 
Figure 4.1 LIVE/DEAD staining of cells on crosslinked matrices. Cells are stained with calcein AM 
for live cells (green) and ethidium homodimer-1 for dead cells (red). Cells show high viability on 
uncrosslinked adipose extracellular matrix (A),  5 mM EDC crosslinked (B), and 1% HMDC 
crosslinked in Tween 20 matrices (C).  
4.3.2 Migration assay 
Serum starved ASCs were screened using a Boyden chamber assay to determine whether they 
would migrate towards adipose ECM proteins. A dose-dependent increase in the number of cells 
migrating across the membrane was observed with the addition of adipose ECM to the media, 
similar to that observed with the positive control of 10% FBS (Fig 4.3A).  
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4.3.3 Adipogenic differentiation of cells in 2D culture on the adipose matrices 
ASCs adhered and spread on positively-charged, coated glass slides. When cultured on 200 um 
thick sections of adipose matrix collected on the glass slides, cells preferentially adhered to the 
adipose matrix over areas of exposed glass and adapted a spindle-shaped morphology that was 
less spread than cells cultured directly on the glass slides. With the addition of adipogenic 
induction media, cells underwent adipogenic differentiation and began accumulating lipid 
droplets that stained positively with Nile Red (Fig 4.2). 
 
Figure 4.2 In vitro adipogenesis of ASCs seeded on adipose matrix in 2D culture. ASCs seeded on 
glass slides (A), 200 um sections of adipose ECM (B), and on adipose ECM sections with adipogenic 
differentiation media (C). 
4.3.4 Adipogenic differentiation of cells in 3D constructs comparing the adipose and 
dermis ECM 
Efficiency of adipogenic differentiation of ASCs was compared on adipose and dermal 
extracellular matrices in a 3D culture environment more representative of the native adipocyte 
environment. The ASCs were resuspended in either adipose ECM or acellular dermis and at the 
end of 15 days in culture, looked indistinguishable upon gross examination (Fig 4.3B). After 
cryosectioning, histological sections of the constructs were stained with Oil Red O to stain for 
lipid accumulation, which is one of the hallmarks of adipogenic differentiation (Fig 4.3C). 
Hematoxylin and eosin staining showed similar cell distribution and morphologies between cells 
grown on the two scaffolds. Gene expression supported the results from the Oil Red O staining 
as cells grown on the adipose matrix had higher expression of adipogenic genes for both early 
and late markers of adipogenesis compared to cells grown on the dermal matrix (Fig 4.3 D) 
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Figure 4.3 In vitro chemoattractive properties and adipo-inductive capacity of the adipose matrix. 
Migration of ASCs in response to an adipose ECM gradient using a Boyden chamber assay (A). 3D 
construct culture of ASCs in acellular dermis and adipose ECM (B). Oil red O staining for 
adipogenesis from both the edge and center of the constructs and hematoxylin and eosin staining of 
cells cultured in adipose and dermis ECM (C). Gene expression of adipogenic markers for cells 
cultured in the two matrices (D). 
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4.3.5 HUVEC tube formation assay 
HUVECs seeded on Matrigel form capillary-like structures within several hours of seeding. The 
tube formation can be enhanced with the addition of angiogenic factors in the media such as the 
growth factors commonly used in endothelial growth media. Since growth factors are naturally 
found in the basic Matrigel preparation, the use of growth factor-reduced Matrigel in the tube 
formation assay allows us to evaluate this angiogenic potential against a less potent background. 
HUVECs begin to branch out and form immature networks when cultured in EBM but are 
unstable over long periods in culture. The addition of adipose ECM enhances network formation 
in EBM, resulting in more branching and contacts between neighboring cell aggregates. In EGM, 
HUVECs develop more mature vascular networks with extensive branching. The addition of 
adipose matrix resulted in a slight increase in the branching and network formation (Fig 4.4).  
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Figure 4.4 HUVEC tube formation assay with adipose ECM. Soluble adipose ECM was added to 
either endothelial basal media or endothelial growth media to evaluate vascular network formation 
of HUVEC cells seeded on Matrigel after 6 hours (A). Parameters of branching networks were 
quantified using the Angiogenesis Analyzer for ImageJ (B).  
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4.4 Discussion 
In these studies, we were able to investigate the ability of the adipose matrix to support cell 
adhesion, growth, and differentiation. Even with chemical crosslinking of the adipose ECM, 
cells showed high viability and adhered to the matrix. Chemical crosslinkers often are very toxic 
to cells and any uncrosslinked molecules must be completely removed through the rinsing steps. 
There is also the risk that crosslinking will alter the protein structures to an extent that cells will 
no longer recognize them as the original matrix, thus losing any bioactivity through the 
crosslinking process. These concerns did not end up materializing and the matrices were capable 
of supporting cell survival in vitro.  
In the culture of ASCs on sections of adipose ECM attached to glass slides, the ASCs 
preferentially bound to the adipose matrix even when they had equal access to the glass surface 
and adopted a spindle-like morphology. The cells appeared to have a natural affinity for the 
ECM scaffold and it is likely that it provided a more natural surface for their growth compared to 
the glass slides. The cells also differentiated and initiated formation of lipid droplets with the 
addition of adipogenic induction media, demonstrating that the adipose matrix could indeed 
support adipogenic differentiation of the cells. However, the adipose matrix was not sufficient 
alone, and required the addition of the adipogenic factors to induce differentiation.  
We also investigated the bioactive properties of the adipose extracellular matrix in the in 
vitro environment. The adipose matrix had chemoattractive properties and guided stem cell 
migration in similar fashion to FBS in a migration assay, suggesting that there is likely an 
optimal gradient to which stem cells are inclined to migrate towards ECM-based scaffolds. This 
is supported by studies that have found that mesenchymal stem cells home to areas of tissue 
injury in vivo and contribute to the wound healing response.144,145 In sites of tissue injury, 
fragments of ECM can potentially provide the local trophic factors to induce stem cell 
migration.139 More importantly, this highlights the potential of utilizing the acellular scaffolds to 
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facilitate cell migration and tissue regeneration, and bypassing the need to deliver exogenous 
cells for tissue repair.  
Despite the increased use of extracellular matrix-based approaches to tissue regeneration, 
tissue specificity of the extracellular matrix remains an enigma as it remains unclear which 
tissues are optimal for specific applications. In this study we compared the efficacy of 
adipogenic differentiation on adipose and dermal ECM to determine whether the tissue 
specificity of the matrices is retained through all the decellularization procedures. We found that 
ASCs cultured on the adipose matrix showed improved adipogenic differentiation by gene 
expression and histological markers, suggesting that tissue-specific factors may render particular 
tissues more appropriate for certain applications. Thus, care must be taken in deciding the 
starting material as the tissue of origin does impart different bioactive cues that control the 
cellular microenvironment. This is further supported by studies that have identified differences 
in the ECM composition of distinct tissues and organs.126 Additionally, other groups have found 
that extracting protein components from the extracellular matrix of adipose tissue has adipo-
inductive effects and can lead to adipogenic differentiation of stem cells.76,77 
To date, attempts to generate adipose tissue constructs in vitro have been met with mixed 
success. One of the major challenges is to get adipogenic differentiated cells to adopt the 
unilocular morphology characteristic of adipocytes in the native environment. Although it has 
been well established that multipotent stem cells can be differentiated toward the adipogenic 
lineage with a defined set of media components in 2D culture, differentiated cells tend to 
accumulate multiple small lipid droplets as opposed to a single large lipid droplet similar to their 
native morphology in adipose tissue. Fischbach et al were able to do this successfully with poly 
glycolic acid scaffolds seeded with 3T3-L1 preadipocytes, which produced constructs that 
looked morphologically similar to native adipose tissue after long term culture in vitro.15,16  
Difficulties in histological sectioning of some of these materials are also likely to be a factor 
in the mixed outcomes observed in the literature. Oil Red O staining requires cryosectioning so 
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that the lipids are not processed away, and this can contribute to histological artifacts in sections. 
In most cases, cells are sparsely distributed in the matrix and are not in close approximation with 
each other, as found in native adipose tissue. Additionally lipid accumulation is not as drastic as 
in native adipose tissue where lipids disproportionately take up the majority of the cell volume. 
Specific in vitro culture conditions can improve outcomes for generating adipose tissue 
constructs, such as the use of dynamic culture either with a stirred bioreactor or on an orbital 
shaker, which improves tissue production and maintenance of larger tissue constructs by 
enhancing nutrient diffusion.15,39  
Nonetheless, these engineered constructs are intended for in vivo use and as a result, the 
tissues need not be fully formed at the time of implantation. Instead many researchers try to 
capitalize on the host in vivo regenerative processes to complete tissue maturation in the 
constructs. Our studies demonstrated that the adipose ECM can serve as a biological scaffold for 
adipose tissue engineering. It provides a supportive environment for stem cell adhesion and 
differentiation and its biological properties make it advantageous for application in soft tissue 
regeneration. These aspects of the ECM, along with its availability and potential for allogenic 
use make it uniquely suited for soft tissue repair. 
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5. The Adipose Extracellular Matrix as a Scaffold for In Vivo 
Adipose Tissue Regeneration 
5.1 Introduction 
Soft tissue damage can occur as a result of traumatic injury, congenital and acquired medical 
conditions, infection, or ablative surgical procedures like tumor resection. Intensive 
reconstructive surgeries are often required to repair these defects to improve aesthetic outcomes 
and often rely on the use of autologous tissue flaps for the reconstruction. The major drawback 
of this approach is the requirement of a donor site to provide tissue for the reconstruction, which 
can result in significant donor site morbidities.107 In cases of extensive soft tissue loss such as 
injuries sustained from blast trauma, availability of donor sites can become limited as multiple 
flap reconstructions are required. Additional complications can include infection, necrosis, 
thrombosis, hematoma, and flap loss.12,141 Another approach for repairing smaller volume defects 
is to perform fat grafting. In this procedure, patients undergo liposuction and the collected 
lipoaspirate is injected at the defect site. This technique suffers from high variability in the rates 
of resorption and poor viability of transplanted adipose tissue, which leads to necrosis and cyst 
formation.8,10  
Current engineered approaches to regenerate adipose tissues have used both synthetic and 
naturally-derived biomaterials.118 The extracellular matrix of tissues (ECM) is composed of a 
network of structural proteins and proteoglycans that provide both mechanical and biochemical 
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support for the parenchymal cells of the tissue. The ECM is an intriguing prospect as a 
biomaterial for tissue regeneration since it is the native environment that cells are found in and 
can potentially retain biological signals from its tissue of origin that may aid in regeneration.   
Decellularized lipoaspirate has been processed into various formulations including 
injectable powders, sheets, and pepsin digested to form a hydrogel for adipose regeneration.82-86 
Others have extracted proteins from the extracellular matrix in a preparation similar to Matrigel, 
forming a temperature hydrogel that forms a gel at physiological temperatures.76,77 Intact 
decellularized adipose matrices have been used as an acellular scaffold and formulated into 
microcarriers and foams for use as a scaffold in vivo.87,89,90 However, many of the approaches 
lose structural integrity of the ECM with enzyme digestion and acid solubilization, or extract 
only specific fractions of the adipose matrix.  
In this study, we introduce a method of decellularizing intact adipose tissue to obtain a bulk 
extracellular matrix scaffold that is minimally processed to retain as much of the original 
structure as possible. The use of a bulk extracellular matrix would be advantageous since it 
would more effectively fill a volume defect and provide the structural support required while 
encouraging host tissue regeneration to take place. Additionally, we monitor the long term 
volume retention of the scaffold in vivo and compare it with the current clinical standard of fat 
grafting.  
5.2 Materials and Methods 
Materials were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
5.2.1 Adipose extracellular matrix preparation 
Subcutaneous adipose tissue was subjected to mechanical processing and extensive rinsing, 
followed by incubation with 3% peracetic acid for 3 hours to remove cells. Samples were 
brought back to physiological pH using PBS and incubated overnight with 1% Triton X-100 in 2 
mM EDTA to remove residual lipids, followed by detergent removal with rinsing the next day.  
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5.2.2 In vivo studies 
All animal studies were conducted with approval by the Johns Hopkins Animal Care and Use 
Committee. 
In vivo biocompatibility of crosslinked adipose ECM  
A total of 18 subcutaneous injections (6 per crosslinking condition) were carried out in two 
male and two female Sprague-Dawley rats (n=4) between 4-13 weeks old. The following 
conditions were used: uncrosslinked control, 5 mM EDC-crosslinked, and 1% HMDC-
crosslinked in Tween 20, with 300 ul injections of each condition along the dorsum. Implants 
were removed after 2 and 3 weeks and fixed for histology.  
Long term biocompatibility 
Upon completion of the initial study, a longer term study was carried out with 6-week old female 
Sprague Dawley rats (n=12) over the course of 12 weeks. Animals were grouped by study 
endpoints of 1, 4, and 12 weeks with 4 animals per timepoint. 200 ul injections of uncrosslinked 
adipose-derived matrix were performed subcutaneously in the rats to characterize the immune 
response and tissue remodeling without introducing additional crosslinkers, which can 
potentially elicit a more severe inflammatory response. 
In vivo volume retention compared to fat grafting 
Athymic mice (n=8) were used to evaluate the volume retention of the adipose ECM in 
comparison to the clinical standard of fat grafting. Human lipoaspirate was obtained from 
patients undergoing liposuction with prior approval by the Institutional Review Board. A 
solution containing normal saline with 1:500,000 epinephrine was infiltrated into the area at a 
ratio of 1 ml of solution per ml of fat and adipose tissue was aspirated using a 2.5 mm diameter 
blunt tip cannula attached to a 10-ml Luer-lock syringe, creating light negative pressure by 
slowly withdrawing the plunger in a gradual manner. Lipoaspirate was washed three times with 
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normal saline added at a 1:1 ratio and allowed to decant at room temperature for five minutes 
between each wash to aid in removal of blood and infiltration fluids. Excess saline was removed 
and 200 ul of lipoaspirate was loaded in syringes for injection.  
Subcutaneous injections of lipoaspirate and adipose ECM were injected along the dorsum 
of the athymic mice. Each mouse received a 200 ul injection of each condition and volume 
measurements were taken using digital calipers. Volume persistence was monitored with regular 
measurements starting at day 0 immediately after injection and continued every two weeks until 
the study endpoint of 12 weeks. At the conclusion of the study, implants were removed and fixed 
for histology. 
In vivo adipogenesis of adipose ECM with ASCs 
Subcutaneous adipose tissue was obtained from patients undergoing abdominoplasty procedures 
with approval from Johns Hopkins Medicine Institutional Review Board. Adipose-derived stem 
cells (ASCs) were isolated by digestion with 1 mg/mL collagenase I (Worthington) in DMEM F-
12 (Gibco) for 1.5 hours on an orbital shaker at 37°C. The resulting cell suspension was 
centrifuged and filtered through 70 uM and 40 uM cell strainers. ASCs were seeded at 5,000 
cells/cm2 and cultured in DMEM-F12 supplemented with 10% fetal bovine serum (Thermo 
Scientific HyClone). Cells were used between passages 3-5 for all studies.  
To evaluate whether in vivo adipogenesis could be enhanced by the addition of ASCs, a 
combined approach with adipose ECM and stem cell delivery was used. ASCs were expanded 
and resuspended with 200 ul of adipose ECM right before injection. Athymic mice (n=12) 
received injections of adipose ECM with and without 2 million ASCs. Volume persistence was 
monitored with digital calipers starting 24 hours after initial injection at day 1 to prevent over 
manipulation of the implants and measured at regular intervals every 2 weeks. Implants were 
removed from 4 mice at each of the study timepoints of 1, 4, and 12 weeks for histological 
analysis.  
     49
 
5.2.3 Histology 
Specimens for paraffin embedding were fixed with 10% formalin, dehydrated through graded 
ethanol solutions, cleared in xylene, and embedded in paraffin. Samples were sectioned at 5 um 
thickness and stained with hematoxylin and eosin or Masson’s trichrome. For Oil Red O (0.75% 
(w/v) in 36% triethyl phosphate) staining of lipids, samples were fixed and infiltrated with 
graded sucrose solutions, followed by OCT embedding and cryosectioned in order to visualize 
new adipose tissue formation.  
5.2.4 Immunostaining 
Antigen retrieval was performed using heat-induced epitope retrieval with sodium citrate buffer. 
Deparaffinized and rehydrated slides were boiled in 10 mM sodium citrate, 0.05% Tween-20, pH 
6 for 30 minutes at 100°C. Sections were blocked with 10% normal goat serum or 1% BSA for 2 
hours at room temperature and incubated with primary antibody overnight at 4°C. Secondary 
antibodies were applied the next day and incubated for 2 hours at room temperature. Slides were 
coverslipped with Vectashield + DAPI and sealed. The following primary antibodies were used: 
mouse anti-human nuclei (Millipore), and mouse anti-rat CD44 (BD Pharmingen, San Diego, 
CA), and mouse anti-CD31 (Abcam). The secondary antibodies for fluorescent detection were 
Alexafluor 488 goat anti-mouse IgG1 (Invitrogen) and Alexafluor goat anti-mouse IgG2a. The 
SuperPicture Mouse DAB Kit (Invitrogen) was used for chromogen detection.  
5.3 Results 
5.3.1 In vivo biocompatibility of crosslinked adipose ECM  
The in vivo study was carried out with control, 5 mM EDC, and 1% HMDC in Tween 20 
crosslinked ECM. After two weeks of implantation, adipose ECM implants were opaque and 
vascularization could be observed at the surface (Fig 5.1). Adipose tissue development was 
observed at the periphery of the implant. No sign of a severe immune response was evident, but 
a focal acute inflammatory response was observed at the periphery, extending inwards. The 
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inflammatory reaction was primarily comprised of lymphocytes and neutrophils and the most 
prominent fibrous capsule formed with the 5 mM EDC crosslinked ECM. 
 
Figure 5.1 In vivo biocompatibility of crosslinked matrices. Gross (A-C) and histological images (E-
F) of adipose matrix from the in vivo rat study for uncrosslinked control (A, D), 5 mM EDC 
crosslinked (B, E), and 1% HMDC crosslinked ECM (C, F). Specimens are stained with Masson’s 
trichrome and the adipose-derived matrix is denoted by an asterisk. 
 
5.3.2 Long term biocompatibility 
In the long term study, the adipose-derived matrix developed into newly formed adipose tissue at 
the edges near the scaffold interface with host subcutaneous tissue. Oil Red O staining 
accentuated the band of adipose tissue forming from the edges of the implant at four weeks (Fig 
5.2). Additionally, cells in the center of the matrix stained positive for CD31, indicating vascular 
development, which is the necessary prerequisite for formation of new adipose tissue. A number 
of cells also stained positive for CD44, a  cell surface receptor for hyaluronic acid that is 
expressed on both cells of hematopoietic and non-hematopoietic origin and is involved in 
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lymphocyte homing. By 12 weeks, the adipose tissue development continued in the implant and 
areas of collagen remodeling were observed by histology (Fig 5.3). 
 
 
Figure 5.2 In vivo biocompatibility in a rat model. Histology of adipose ECM implants after  four 
weeks in Sprague Dawley rats stained with hematoxylin and eosin (A), Oil red O for lipids (B), 
CD31 (C), and CD44 (D). 
 
 
Figure 5.3 De novo adipogenesis at implant periphery. At 12 weeks in the subcutaneous rat study, 
adipose matrix implants show substantial areas of adipose tissue development and collagen 
remodeling by host cells. 
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5.3.3 In vivo volume retention compared to fat grafting 
There was no significant difference in the volume persistence between adipose ECM implants 
and lipoaspirate fat grafts (Fig 5.4). At one week post implantation, there was slightly more 
swelling for the adipose ECM implants compared to fat grafts whereas fat grafts just showed a 
continual decrease in volume after injection. Once the swelling subsided, the volume retention of 
the two conditions was nearly indistinguishable. Upon gross examination of the implants at 12 
weeks, the adipose ECM implants were white in color in contrast to the characteristic yellow 
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I F 
Figure 5.4 Comparison of in vivo fat grafting and adipose ECM. Volume persistence of the fat grafts 
and adipose ECM measured with digital calipers (A). Gross images of the adipose ECM (B) and 
human lipoaspirate fat graft (C) at the end of the 12 week study period. Hematoxylin and eosin 
staining of the fat graft (D-F) with signs of calcification (E) and cyst formation (F). Hematoxylin and 
eosin staining of human adipose ECM implants (G-I). High magnification images showing 
adipogenesis (H) and vascularization within the implant (I). 
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Histology of the adipose fat graft showed a layer of viable adipocytes around the edges, but 
a central necrotic cyst had formed in the center. Areas of calcification were also observed, which 
typically occur secondary to necrosis and phagocytes were observed in the implant area, clearing 
away lipid and cell debris. Hematoxylin and eosin staining of the adipose matrix showed the 
scaffold largely remained, with few areas of adipose tissue formation along the periphery. There 
was also some vascularization in the matrix and minimal inflammation.  
5.3.4 In vivo adipogenesis of adipose ECM with ASCs 
To determine if adipogenesis could be improved with the addition of ASCs to the matrix, ASCs 
were expanded in culture and resuspended with the adipose matrix just prior to delivery by 
subcutaneous injection in an athymic mouse model (Fig 5.5). The volume persistence showed 
that the adipose matrix alone maintained a constant volume throughout the study period. The 
adipose matrix with ASCs showed a slight decrease between weeks 4-10 but stabilized 
thereafter.  
The histology of the acellular adipose matrix scaffold was similar to the results obtained in 
the previous study, with the adipose matrix maintaining volume stability and the scaffold 
remaining largely in place. Staining of the adipose matrix with cells at 12 weeks showed 
extensive de novo adipose tissue formation. Much of the implant was replaced by new adipose 
tissue with the edges completely populated by new adipocytes and progressing inward to the 
center of the implant, with small areas in the center where the original scaffold was still visible. 
The remaining areas of the adipose matrix were sites with high levels of activity and matrix 
remodeling, as evidenced by the staining pattern of the collagen-based scaffold.  
Immunostaining was performed to determine whether the implanted human ASCs still 
remained in the scaffold and at 12 weeks, ASCs were observed in the implant, staining positively 
for antibodies against cells of human origin. It is unclear whether the ASCs have differentiated 
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into adipocytes or whether they remain in the stroma and adopt a supportive role in facilitating 
new adipose tissue formation.   
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Figure 5.5 In vivo adipogenesis for adipose ECM with ASC delivery. Gross images of an adipose 
ECM implant (A) and adipose ECM with ASCs (B) at the end of 12 weeks in an athymic mouse 
model (C). Volume measurements of both conditions using digital calipers (D). Histology with 
hematoxylin and eosin staining of the adipose ECM with ASCs at 12 weeks (E). High magnification 
images of areas of new adipose tissue formation (F) and immunostaining for anti-human nuclei to 
identify implanted human cells at 12 weeks (G). 
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5.4 Discussion 
Our studies showed that a decellularized ECM biomaterial can be derived from adipose tissue to 
obtain a biocompatible scaffold for the repair of soft tissue defects. Crosslinking the 
decellularized scaffold provided an additional element of control over the degradation properties 
of the tissue and allows the material to be tailored to the target site of implantation. In vivo 
implantation in rats revealed good tissue integration with adipose tissue development starting at 
the edges of the ECM scaffold.  
The adipose-derived matrix supported cell migration and infiltration, with a considerable 
number of host cells at the center of the implant for the uncrosslinked control and 1% HMDC 
crosslinked matrices. There was a more prominent fibrous capsule observed for the crosslinked 
matrices, so while they do not appear to elicit a severe inflammatory reaction, fewer cells 
migrate into the scaffold. In the long term in vivo study, adipogenesis was observed at the 
periphery of the implant, suggesting that despite the acellular nature of the implant, the bioactive 
properties of the matrix render it conducive to host cell migration, which could be sufficient for 
tissue regeneration. The adipose scaffold was able to maintain a stable volume, proving efficacy 
in restoring contour and maintaining a volume correction.  
 When the volume retention of the adipose ECM was compared to the clinical standard of 
fat grafting, the retention rates were comparable and were not significantly different. Regarding 
in vivo efficacy, the adipose matrix performed just as well as fat grafting and would thus provide 
patients with an alternative in which they would no longer need to undergo a surgical procedure 
of liposuction to collect the required lipoaspirate. Instead, the adipose matrix could be produced 
as an off-the-shelf product that could be used allogenically. Histology of the fat grafts revealed 
the troubling disadvantages of fat grafting. At 12 weeks, a defined central necrotic cyst had 
formed with several smaller cysts throughout the implant and areas of calcification. Higher 
levels of inflammation were also observed as phagocytic cells migrate into the graft to clear 
away nonviable adipocytes and residual intracellular lipid.  
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Adipocytes in their native environment each have access to at least one blood vessel for 
oxygen and nutrient exchange. During the fat grafting procedure, adipocytes are ripped from 
their native environment and reinjected at another site of the body. Adipocytes are fragile by 
nature, due to the oversized lipid droplet they safeguard and are easily ruptured by the negative 
pressure applied during liposuction. Once injected in their new site, adipocytes in the center no 
longer have access to a blood supply and these metabolically active cells undergo necrosis. 
Surgeons have developed numerous protocols to improve viability of the grafted cells by 
injecting into small channels rather than a bolus, using more involved preparations of 
lipoaspirate such as centrifugation or washing, and adding stromal vascular cells to aid in graft 
survival. However the unpredictable rates of resorption and lack of standardization of techniques 
remain a problem.  
Thus, one of the distinct advantages of the adipose ECM compared to fat grafting is that the 
high metabolic burden of transplanting adipocytes is bypassed. Instead, the adipose ECM is an 
acellular graft that relies on host cells to migrate into the scaffold and repopulate it to form new 
tissue. This also ensures that the rate of vascularization is coupled with the rate of new adipose 
tissue formation to generate sustainable adipose tissue with high cell viability.  
In the final in vivo study, the adipose matrix scaffold was investigated as a delivery vehicle 
for ASCs. The rationale behind the approach was twofold: first, the adipose stem cells could 
enhance adipogenesis by differentiation into adipocytes and secretion of paracrine factors, and 
second, the adipose matrix could provide a protective environment for stem cell engraftment and 
survival. The ASCs were just expanded in culture prior to differentiation and not 
predifferentiated, so any induction of adipogenesis was not due to addition of exogenous factors. 
The addition of the ASCs drastically improved de novo adipogenesis compared to delivery of the 
acellular adipose matrix. At 12 weeks, the adipose scaffold is almost entirely replaced by new 
adipose tissue whereas scaffolds without the inclusion of cells had adipogenesis only at the 
periphery of the implant. The mechanisms by which the ASCs speed up this process of 
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adipogenesis are still unclear. With immunostaining, we found that the ASCs were still present 
in the implants at week 12, but it was impossible to elucidate whether they had differentiated 
into adipocytes or if they remained in the stromal compartment.  
Promising developments in point-of-care systems for automated isolation of stromal 
vascular cells from lipoaspirate could make intraoperative isolation of a patient’s own cells 
possible. ASCs do not have the high metabolic demands of the adipocytes from the previous 
study and have been found to have significant immunomodulatory and paracrine activity.146 The 
use of combined cell-scaffold delivery approaches to tissue regeneration may soon be realized 
with technological advances that will allow for automatic isolation of adipose stromal cells.  
To date, intact adipose-derived ECM has not been studied extensively in vivo for use in soft 
tissue repair, but results from this study suggest that adipose tissue can be effectively 
decellularized and stripped of its antigenic components to produce a biocompatible matrix for 
adipose tissue engineering. The adipose matrix can be used as an acellular scaffold for filling 
soft tissue defects, or it can be used in conjunction with delivery of progenitor cells to enhance 
new tissue formation. The acellular scaffold is sufficient in restoring volume for most soft tissue 
defects but there may be cases where the regenerative activity of ASCs may be beneficial. In 
areas known to have poor regenerative capacity such as irradiated tissue beds or scarring from 
burn wounds, ASC delivery may be ideal for encouraging tissue regeneration.  
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6. Discussion and future work 
In this dissertation we have demonstrated the development of an adipose extracellular 
matrix-based biomaterial. By removing the cells and lipids from human adipose tissue, we 
obtained a biocompatible scaffold for soft tissue repair. The degradation properties of the 
adipose matrix can be modulated through chemical cross-linking, allowing the user to tune the 
rate of degradation based on the rate of tissue regeneration. The adipose matrix was further 
characterized to determine the protein composition of the ECM. Through mass spectrometry, the 
proteomic profile of the adipose matrix was acquired, allowing us to identify the proteins and 
proteoglycans that constitute the adipose ECM. The mechanical and thermal properties of the 
matrix were measured with rheology and differential scanning calorimetry, respectively, 
providing a complete characterization of the material properties.  
We next evaluated the cell response to the adipose-derived biomaterial through in vitro 
studies. Through migration studies with adipose-derived stem cells, we found that the adipose 
matrix had chemoattractive properties that guided stem cell migration, which would benefit in 
vivo tissue regeneration. The adipose matrix supported cell adhesion, providing an environment 
conducive to cell growth and differentiation. To investigate whether there was tissue specificity 
in extracellular matrices from different tissues, we compared the adipogenic differentiation of 
adipose-derived stem cells on adipose and dermal matrices. Results from the study showed that 
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the adipose matrix did improve adipogenic differentiation, supporting unique tissue-specific 
bioactivity of the adipose matrix. 
Finally, we investigated the in vivo host response to the adipose matrix. The acellular 
scaffolds were well tolerated in vivo and had minimal inflammatory response, even with 
chemical cross-linking. Over 12 weeks, the volume persistence was steady, proving efficacy of 
the adipose matrix in maintaining a volume correction. When compared with the clinical 
standard of fat grafting, the acellular adipose scaffold had clear advantages since there was no 
cellular component that needed to be transplanted. Limited cell viability in the fat grafts led to 
necrosis and inflammation, which in turn caused cyst formation and calcification over the course 
of the study. Alternatively, the adipose matrix can also be used as a delivery vehicle for adipose-
derived stem cells. The addition of the stem cells enhanced adipogenesis in the scaffold, 
resulting in significant new adipose tissue formation, replacing much of the original scaffold at 
12 weeks.  
Through this work, we have established a novel adipose-derived biomaterial that facilitates 
adipose tissue regeneration. The adipose matrix presents an off-the-shelf alternative for repairing 
soft tissue defects that would circumvent the need for donor site tissue for reconstruction, 
thereby preventing donor site morbidities for the patient. Future directions for this work include 
elucidating differences in the adipose extracellular matrix derived from different adipose tissue 
depots of the body and disease-related changes to the extracellular matrix, such as in a diabetic 
donor. Additionally, further studies would need to be carried out to reveal the mechanisms by 
which adipose-derived stem cells enhance adipogenesis in the cell plus scaffold approach. It is 
still unclear whether the adipose-derived stem cells act by paracrine factors or if they fully 
differentiate into adipocytes to contribute to the new adipose tissue formation. If the activity is 
indeed attributed to the secretion of trophic factors, one would ideally be able to identify which 
factors are responsible and incorporate them into the scaffold design in order to harness the 
beneficial effects of the ASCs without having to perform cell transplantation. Thus, the adipose 
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extracellular matrix serves as a foundation for new adipose tissue growth, making it a promising 
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